BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15276404)

  • 1. Arsenic toxicity at low doses: epidemiological and mode of action considerations.
    Schoen A; Beck B; Sharma R; Dubé E
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):253-67. PubMed ID: 15276404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk?
    Snow ET; Sykora P; Durham TR; Klein CB
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):557-64. PubMed ID: 15996700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seafood arsenic: implications for human risk assessment.
    Borak J; Hosgood HD
    Regul Toxicol Pharmacol; 2007 Mar; 47(2):204-12. PubMed ID: 17092619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk assessment of arsenic-induced internal cancer at long-term low dose exposure.
    Liao CM; Shen HH; Chen CL; Hsu LI; Lin TL; Chen SC; Chen CJ
    J Hazard Mater; 2009 Jun; 165(1-3):652-63. PubMed ID: 19062162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addressing nonlinearity in the exposure-response relationship for a genotoxic carcinogen: cancer potency estimates for ethylene oxide.
    Kirman CR; Sweeney LM; Teta MJ; Sielken RL; Valdez-Flores C; Albertini RJ; Gargas ML
    Risk Anal; 2004 Oct; 24(5):1165-83. PubMed ID: 15563286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic-induced carcinogenesis--oxidative stress as a possible mode of action and future research needs for more biologically based risk assessment.
    Kitchin KT; Conolly R
    Chem Res Toxicol; 2010 Feb; 23(2):327-35. PubMed ID: 20035570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health effect levels for risk assessment of childhood exposure to arsenic.
    Tsuji JS; Benson R; Schoof RA; Hook GC
    Regul Toxicol Pharmacol; 2004 Apr; 39(2):99-110. PubMed ID: 15041143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral exposure to inorganic arsenic: evaluation of its carcinogenic and non-carcinogenic effects.
    Schuhmacher-Wolz U; Dieter HH; Klein D; Schneider K
    Crit Rev Toxicol; 2009; 39(4):271-98. PubMed ID: 19235533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites.
    Kitchin KT
    Toxicol Appl Pharmacol; 2001 May; 172(3):249-61. PubMed ID: 11312654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research toward the development of a biologically based dose response assessment for inorganic arsenic carcinogenicity: a progress report.
    Clewell HJ; Thomas RS; Gentry PR; Crump KS; Kenyon EM; El-Masri HA; Yager JW
    Toxicol Appl Pharmacol; 2007 Aug; 222(3):388-98. PubMed ID: 17499324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview on chronic arsenism via drinking water in PR China.
    Xia Y; Liu J
    Toxicology; 2004 May; 198(1-3):25-9. PubMed ID: 15138026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic health effects in people exposed to arsenic via the drinking water: dose-response relationships in review.
    Yoshida T; Yamauchi H; Fan Sun G
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):243-52. PubMed ID: 15276403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Water intake in an Asian population living in arsenic-contaminated area.
    Watanabe C; Kawata A; Sudo N; Sekiyama M; Inaoka T; Bae M; Ohtsuka R
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):272-82. PubMed ID: 15276406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Water consumption patterns in rural Bangladesh: are we underestimating total arsenic load?
    Milton AH; Rahman H; Smith W; Shrestha R; Dear K
    J Water Health; 2006 Dec; 4(4):431-6. PubMed ID: 17176814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Weibull-PBPK model for assessing risk of arsenic-induced skin lesions in children.
    Liao CM; Lin TL; Chen SC
    Sci Total Environ; 2008 Mar; 392(2-3):203-17. PubMed ID: 18207220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic drinking water regulations in developing countries with extensive exposure.
    Smith AH; Smith MM
    Toxicology; 2004 May; 198(1-3):39-44. PubMed ID: 15138028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk characterization and exposure assessment in arseniasis-endemic areas of Taiwan.
    Ling MP; Liao CM
    Environ Int; 2007 Jan; 33(1):98-107. PubMed ID: 17014909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of arsenic exposure during pregnancy with fetal loss and infant death: a cohort study in Bangladesh.
    Rahman A; Vahter M; Ekström EC; Rahman M; Golam Mustafa AH; Wahed MA; Yunus M; Persson LA
    Am J Epidemiol; 2007 Jun; 165(12):1389-96. PubMed ID: 17351293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-level arsenic exposure in drinking water and bladder cancer: a review and meta-analysis.
    Mink PJ; Alexander DD; Barraj LM; Kelsh MA; Tsuji JS
    Regul Toxicol Pharmacol; 2008 Dec; 52(3):299-310. PubMed ID: 18783726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of background inorganic arsenic exposures to provide perspective on risk assessment results.
    Tsuji JS; Yost LJ; Barraj LM; Scrafford CG; Mink PJ
    Regul Toxicol Pharmacol; 2007 Jun; 48(1):59-68. PubMed ID: 17346867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.